Every 8-K that GROVE COLLABORATIVE WTS (GROVW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow GROVW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GROVW filings page.
Grove Collaborative Holdings, Inc. (GROV) reported board changes effective August 27, 2026. Director Naytri Shroff Sramek resigned from the board, where she chaired the Sustainability, Nominating and Governance Committee and served on the Audit Committee. The company states there were no disagreements regarding operations, policies, or practices and no written statement accompanying her resignation.
The board appointed Jason Karp as a Class III director with a term expiring at the 2028 annual meeting of shareholders and determined he qualifies as an independent director under New York Stock Exchange listing standards. Karp brings experience founding and leading consumer and health-focused businesses and investment funds. He will enter into the company’s standard indemnification agreement and will not receive compensation for board service. Director John Replogle was appointed to the Audit Committee to replace Sramek, and the Sustainability, Nominating and Governance Committee was reduced from three to two directors.
Grove Collaborative Holdings, Inc. reported that on August 7, 2026 it received a notice from the New York Stock Exchange stating that it is not in compliance with Section 802.01B of the NYSE Listed Company Manual, which requires an average global market capitalization of at least $50 million over a consecutive 30 trading-day period and stockholders’ equity of at least $50 million. The company must submit a business plan within 45 days showing how it expects to regain compliance within a nine‑month Cure Period. The notice has no immediate impact on the listing of Grove’s Class A common stock, and the shares are expected to continue trading on the NYSE while the company prepares and submits its plan, subject to ongoing compliance with other NYSE continued listing standards. If Grove does not submit an acceptable plan, the NYSE could initiate delisting proceedings.
Grove Collaborative Holdings reported fiscal second-quarter 2026 results with net revenue of $36.6 million, down 16.9% year-over-year but up 1.0% sequentially. Gross margin was 53.6%. Operating expenses fell to $20.4 million, a 27.0% decline, reducing net loss to $0.9 million, a net loss margin of 2.5%.
Adjusted EBITDA was positive $0.5 million with a 1.3% margin, the third consecutive positive quarter, and operating cash flow was $1.3 million. Cash, cash equivalents and restricted cash totaled $11.4 million at June 30, 2026. DTC orders and active customers fell more than 23% year-over-year, while DTC net revenue per order rose 6.1% to $69.19. Plastic Intensity improved to 0.84 pounds of plastic per $100 in net revenue from 0.93 pounds.
For 2026, the company reaffirmed full‑year net revenue guidance of approximately $142.5 million to $152.5 million and Adjusted EBITDA of breakeven to positive low single‑digit millions, and continues to expect sequential net revenue improvement in each remaining quarter of 2026.
Grove Collaborative Holdings, Inc. reported that Chief Financial Officer and Principal Financial Officer Tom Siragusa has given notice of his intention to resign to pursue another opportunity. He will continue in his role until August 16, 2026, while the company conducts a search for a successor. The company stated that his departure is not due to any disagreement over operations, policies, or financial reporting.
The company also held its 2026 annual meeting of stockholders on June 18, 2026. Class I directors Larry Cheng, Stuart Landesberg, and Kristine Miller were elected to serve until the 2029 annual meeting. Stockholders additionally ratified the appointment of Baker Tilly US, LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Grove Collaborative Holdings, Inc. reported first quarter 2026 net revenue of $36.2 million, down 16.8% year-over-year, but delivered positive Adjusted EBITDA of $0.3 million with a 0.8% margin. Net loss narrowed to $1.0 million from $3.5 million a year earlier, reflecting lower operating expenses and higher gross margin of 54.8%, up 180 basis points.
Operating cash flow improved to a $0.7 million outflow from $6.9 million, while cash, cash equivalents and restricted cash totaled $10.4 million as of March 31, 2026. Direct-to-consumer total orders fell 19.2% and active customers declined 18.5%, but net revenue per order rose 2.0% to $67.79 and plastic intensity improved to 0.84 pounds per $100 in net revenue.
The company raised full‑year 2026 net revenue guidance to a range of $142.5 million to $152.5 million and now expects Adjusted EBITDA between breakeven and positive low single‑digit millions, reiterating that first quarter 2026 marked the expected net revenue trough with sequential improvement anticipated for the remaining quarters of 2026.
Grove Collaborative Holdings, Inc. reports that it has regained compliance with the New York Stock Exchange’s quantitative continued listing standard. The NYSE notified the company that, as of March 17, 2026, it meets the minimum market capitalization and stockholders’ equity requirements of Section 802.01B of the NYSE Listed Company Manual.
Grove Collaborative Holdings, Inc. reported fourth quarter 2025 revenue of $42.4 million, down 14.3% year-over-year, as fewer direct-to-consumer orders followed reduced advertising and ecommerce platform disruptions. This was partly offset by $2.9 million of QVC revenue tied to the 8Greens acquisition.
Despite lower sales, profitability improved sharply. Gross margin rose to 53.0%, operating expenses fell 29.7% to $24.1 million, and net loss narrowed to $1.6 million from $12.6 million. Adjusted EBITDA turned positive at $1.6 million with breakeven operating cash flow, while cash, cash equivalents, and restricted cash totaled $11.8 million.
For full year 2025, revenue was $173.7 million, down 14.6%, but net loss improved to $11.7 million and operating expenses declined 20.7%. Plastic Intensity improved to 0.90 pounds per $100 of revenue. For 2026, Grove expects net revenue of $140–$150 million and approximately breakeven Adjusted EBITDA, with revenue troughing in the first quarter and improving as its ecommerce platform stabilizes and customer experience metrics recover.
Grove Collaborative Holdings, Inc. (GROV) furnished an update on investor communications. The company issued a press release announcing its earnings for the quarter ended September 30, 2025, furnished as Exhibit 99.1, and posted an investor presentation, furnished as Exhibit 99.2, on its investor relations website.
The materials are being furnished, not filed, and therefore are not subject to Section 18 liabilities nor incorporated into other filings unless specifically referenced. Grove also listed its primary disclosure channels for material information, including its website, investor site, select social media accounts, press releases, SEC filings, and public calls/webcasts.
Grove Collaborative Holdings (GROV) appointed Tom Siragusa as Chief Financial Officer, effective October 1, 2025. He will continue as the company’s principal financial officer and principal accounting officer. Siragusa, age 35, has led finance roles at Grove since 2019 and previously worked in strategy, transactions, and assurance at Ernst & Young. His annual base salary was set at $320,000, and he received a restricted stock unit grant for 75,000 shares, vesting in twelve equal installments on February 15, May 15, August 15, and November 15 each year, subject to continued employment.
The company entered into a post-termination benefits agreement with Siragusa. If terminated without cause or he resigns for good reason outside a change-in-control period, he is eligible for six months’ base salary, up to six months of employer-paid health coverage, and accelerated vesting equal to six months of time-based awards, with performance conditions deemed at specified levels. During a change-in-control period, time-based equity vests in full and any prior year bonus is payable.